Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 3
2017 2
2018 3
2019 5
2020 6
2021 5
2022 7
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Results by year

Filters applied: . Clear all
Page 1
Burden of disease of chronic pain in Colombia.
Lasalvia P, Gil-Rojas Y, Rosselli D. Lasalvia P, et al. Expert Rev Pharmacoecon Outcomes Res. 2022 Dec;22(8):1261-1267. doi: 10.1080/14737167.2022.2125872. Epub 2022 Sep 25. Expert Rev Pharmacoecon Outcomes Res. 2022. PMID: 36106600
Burden of disease of chronic pain in Ecuador.
Lasalvia P, Gil-Rojas Y, Rosselli D. Lasalvia P, et al. Expert Rev Pharmacoecon Outcomes Res. 2023 Jun;23(5):547-554. doi: 10.1080/14737167.2023.2193689. Epub 2023 Mar 29. Expert Rev Pharmacoecon Outcomes Res. 2023. PMID: 36946473
Efficacy and safety of dabrafenib-trametinib in the treatment of unresectable advanced/metastatic melanoma with BRAF-V600 mutation: A systematic review and network meta-analysis.
Garzón-Orjuela N, Prieto-Pinto L, Lasalvia P, Herrera D, Castrillón J, González-Bravo D, Castañeda-Cardona C, Rosselli D. Garzón-Orjuela N, et al. Among authors: lasalvia p. Dermatol Ther. 2020 Mar;33(2):e13145. doi: 10.1111/dth.13145. Epub 2019 Nov 14. Dermatol Ther. 2020. PMID: 31664762 Review.
Efficacy and safety of dabrafenib-trametinib in the treatment of unresectable or metastatic melanoma with BRAF V600 mutation: A systematic review and network meta-analysis.
Garzón-Orjuela N, Prieto-Pinto L, Lasalvia P, Herrera D, Castrillón J, González-Bravo D, Castañeda-Cardona C, Rosselli D. Garzón-Orjuela N, et al. Among authors: lasalvia p. Dermatol Ther. 2020 Aug 5:e14135. doi: 10.1111/dth.14135. Online ahead of print. Dermatol Ther. 2020. PMID: 32761749 Review.
Pen Devices for Insulin Self-Administration Compared With Needle and Vial: Systematic Review of the Literature and Meta-Analysis.
Lasalvia P, Barahona-Correa JE, Romero-Alvernia DM, Gil-Tamayo S, Castañeda-Cardona C, Bayona JG, Triana JJ, Laserna AF, Mejía-Torres M, Restrepo-Jimenez P, Jimenez-Zapata J, Rosselli D. Lasalvia P, et al. J Diabetes Sci Technol. 2016 Jun 28;10(4):959-66. doi: 10.1177/1932296816633721. Print 2016 Jul. J Diabetes Sci Technol. 2016. PMID: 26920639 Free PMC article. Review.
Burden of Disease Attributable to Obesity and Overweight in Colombia.
Gil-Rojas Y, Garzón A, Hernández F, Pacheco B, González D, Campos J, Mosos JD, Barahona J, Polania MJ, Restrepo P, Lasalvia P, Castañeda-Cardona C, Rosselli D. Gil-Rojas Y, et al. Among authors: lasalvia p. Value Health Reg Issues. 2019 Dec;20:66-72. doi: 10.1016/j.vhri.2019.02.001. Epub 2019 Apr 28. Value Health Reg Issues. 2019. PMID: 31035116 Free article.
The Rise of Colombian Biomedical Publications.
Rincón Rodríguez CJ, Lasalvia P, Rosselli D. Rincón Rodríguez CJ, et al. Among authors: lasalvia p. Rev Colomb Psiquiatr. 2016 Oct-Dec;45(4):270. doi: 10.1016/j.rcp.2016.06.002. Epub 2016 Jul 15. Rev Colomb Psiquiatr. 2016. PMID: 27842741 No abstract available.
30 results